4Bavirti S,,Tayek JA.Low-dose glyburide reduces glucose producionrates in patients with impaired fasting glucose. Metabolism . 2003 被引量：1
5Davies MJ.Insulin secretagogues. Current Medical Research and Opinion . 2002 被引量：1
6M. Massi-Benedetti.Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience. Clinical Therapeutics . 2003 被引量：1
7Drzewoski J,Czupryniak L.Long-term efficacy of steady-dose metformin in type2diabetes mellitus:a retrospective study. Medical Science Monitor . 2003 被引量：1
8Chiasson JL,Josse RG,Gomis R,et al.Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. Journal of the American Medical Association, The . 2003 被引量：1
9Hallsten K,Virtanen KA,Lonnqvist F,et al.Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes . 2002 被引量：1
10Chiasson JL,Josse RG;Gomis R,et al.Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance:the STOP-NIDDM trial[J].JAMA,2003, 290(4):486-494. 被引量：1
